Tufts-New England Medical Center

Boston, Massachusetts 02111

1 studies enrolling now · 82 studies all time

What they study most

Acute Myeloid Leukemia, Adipose Tissue, Anaplastic Astrocytoma, Anemia, Arthritis, Rheumatoid, Autosomal Dominant Polycystic Kidney Disease, Avascular Necrosis, Biliary Tract Cancer, Breast Cancer, Cancer, Carcinoma, Small Cell, Cardiomyopathies

Studies at this site

• Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion — Running, not enrolling
• Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma — Available (expanded access)
• Ceramic-on-Ceramic (COC) 36mm Acetabular Bearing Insert Post Approval Study-New Subjects (COC36mmPAS) — Completed
• Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD) — Completed
• Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders — Completed
• Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer — Completed
• Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia — Completed
• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma — Completed
• Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes — Completed
• Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy — Completed
• Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia — Completed
• Irinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer — Completed
• Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer — Completed
• Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer — Completed
• REDUCE LAP-HF TRIAL II — Running, not enrolling
• Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy — Completed
• Efficacy and Safety of Adult Human Mesenchymal Stem Cells to Treat Steroid Refractory Acute Graft Versus Host Disease (GVHD) — Completed
• Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute Graft Versus Host Disease (GVHD) — Completed
• Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401) — Completed
• Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) — Completed
• Maribavir for Prevention of CMV After Stem Cell Transplants — Completed
• Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer — Completed
• 28mm Ceramic-on-Ceramic Total Hip Replacement Study — Stopped early
• Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Metastatic Pancreatic Cancer — Completed
• A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus — Completed
• Screening and Brief Advice to Reduce Teen Substance Use — Completed
• Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes — Completed
• Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC) — Completed
• Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy — Completed
• Ranolazine Implantable Cardioverter-Defibrillator Trial — Completed
• EMPOWER Clinical Trial: Vagal Blocking for Obesity Control — Completed
• Dose-finding Study of New Tolvaptan Formulation in Subjects With ADPKD — Completed
• Use of Etanercept in the Treatment of Moderate to Severe Lichen Planus — Stopped early
• Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease — Completed
• Safety and Efficacy Study of Photopheresis With UVADEX to Prevent Graft-versus-Host Disease — Completed
• Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease (ADPKD) — Completed
• Study of Pemetrexed and Gemcitabine for Patients With a New Diagnosis of Extensive-Stage Small Cell Lung Cancer — Stopped early
• A Study of Belimumab in Subjects With Systemic Lupus Erythematosus — Completed
• A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies — Completed
• Study of CEP-701 (Lestaurtinib) in Patients With Acute Myeloid Leukemia (AML) — Completed
• Expanded Access Program for Maraviroc At Multiple Centers — Completed
• Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies — Completed
• Safety of Sports for Patients With Implantable Cardioverter-Defibrillators — Completed
• Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings — Completed
• A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outcome — Completed
• Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx — Completed
• Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer — Completed
• Study of Cicletanine for Pulmonary Arterial Hypertension (PAH) — Stopped early
• Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children — Completed
• A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA) — Completed